Viewing Study NCT00483405


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-01-08 @ 10:45 PM
Study NCT ID: NCT00483405
Status: COMPLETED
Last Update Posted: 2017-07-12
First Post: 2007-06-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: LCCC 0421
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View
None NIH View
None NIH View